申请人:Furukubo Shigeru
公开号:US20090182142A1
公开(公告)日:2009-07-16
An aromatic compound represented by the following formula or a pharmaceutically acceptable salt thereof:
, wherein ring A is a heterocyclic ring, ring B is a carbocyclic ring, a heterocyclic ring etc., G
1
, G
2
, G
3
, G
4
and G
5
are CH or N, X is —NH—, —O—, —CH
2
—, etc., Y is —CH
2
—, —CO—, —SO
2
—, etc., Z is a single bond, —CO—, —SO
2
—, —NH—, —O—, —S—, —CONH—, —SO
2
NH—, etc., R
2
is hydrogen, alkyl, alkoxy, halogen, etc., and R
3
is carbocyclic group, heterocyclic group, alkyl, etc.,
is useful as a controlling agent of the function of CCR4 useful for the treatment or therapy for bronchial asthma, atopic dermatitis, etc.
下列的芳香族化合物或其药学上可接受的盐,其化学式如下:其中环A为杂环,环B为碳环、杂环等,G1、G2、G3、G4和G5为CH或N,X为—NH—、—O—、—CH2—等,Y为—CH2—、—CO—、—SO2—等,Z为单键、—CO—、—SO2—、—NH—、—O—、—S—、—CONH—、—SO2NH—等,R2为氢、烷基、烷氧基、卤素等,而R3为碳环基、杂环基、烷基等。该化合物对于控制CCR4功能的作用剂对于治疗或治疗支气管哮喘、特应性皮炎等疾病是有用的。